LigandAI is an AI-guided platform for designing de novo peptide binders against molecular receptors and supporting targeted delivery research. It is intended for scientists, clinicians, and pharmaceutical developers working with therapeutics, lipid nanoparticles, mRNA, and CRISPR payloads.
Ligandal is a Medical & telehealth project. It focuses on designing targeted therapeutic delivery systems and peptide binders for difficult molecular targets. It is built as a B2B product for precision medicine researchers, clinicians, and pharmaceutical developers. It ships for the web, embeddable surfaces, and API.
Behind Ligandal is Ligandal, and it first shipped in 2025. Key capabilities include disease search, peptide design, and target discovery. It exposes integrations via a public API.
Summary written by a language model from the project’s public pages.
What PulseGate has recorded for this listing
Closest matches by what these projects do